175 related articles for article (PubMed ID: 38042220)
41. Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation.
Noubissi Nzeteu GA; Schlichtner S; David S; Ruppenstein A; Fasler-Kan E; Raap U; Sumbayev VV; Gibbs BF; Meyer NH
Front Immunol; 2022; 13():837097. PubMed ID: 35634346
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of immune checkpoint molecules in breast cancer.
Fang J; Chen F; Liu D; Gu F; Chen Z; Wang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32602545
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer.
Hou Z; Pan Y; Fei Q; Lin Y; Zhou Y; Liu Y; Guan H; Yu X; Lin X; Lu F; Huang H
J Cancer Res Clin Oncol; 2021 Feb; 147(2):517-531. PubMed ID: 33237432
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression.
Gao C; Gardner D; Theobalds MC; Hitchcock S; Deutsch H; Amuzie C; Cesaroni M; Sargsyan D; Rao TS; Malaviya R
Clin Exp Immunol; 2021 Dec; 206(3):422-438. PubMed ID: 34487545
[TBL] [Abstract][Full Text] [Related]
45. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
[TBL] [Abstract][Full Text] [Related]
46. FOXD3 Regulates VISTA Expression in Melanoma.
Rosenbaum SR; Knecht M; Mollaee M; Zhong Z; Erkes DA; McCue PA; Chervoneva I; Berger AC; Lo JA; Fisher DE; Gershenwald JE; Davies MA; Purwin TJ; Aplin AE
Cell Rep; 2020 Jan; 30(2):510-524.e6. PubMed ID: 31940493
[TBL] [Abstract][Full Text] [Related]
47. VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation.
Luk SJ; Schoppmeyer R; Ijsselsteijn ME; Somarakis A; Acem I; Remst DFG; Cox DT; van Bergen CAM; Briaire-de Bruijn I; Grönloh MLB; van der Meer WJ; Hawinkels LJAC; Koning RI; Bos E; Bovée JVMG; de Miranda NFCC; Szuhai K; van Buul JD; Falkenburg JHF; Heemskerk MHM
Cancer Immunol Res; 2023 Nov; 11(11):1480-1492. PubMed ID: 37695550
[TBL] [Abstract][Full Text] [Related]
48. Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis.
Luo H; Li J; Lin Q; Xiao X; Shi Y; Ye X; Wei Z; Liu Y; Xu J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33057583
[TBL] [Abstract][Full Text] [Related]
49. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
50. The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma.
Olbromski M; Mrozowska M; Piotrowska A; Smolarz B; Romanowicz H
Cancer Immunol Immunother; 2024 Jun; 73(8):136. PubMed ID: 38833004
[TBL] [Abstract][Full Text] [Related]
51. Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action.
Hu B; Meng X; Zhang Y; Hossain MM; Wu L; Zhang Y; Peng X; Zhang X
Oncol Rep; 2018 Apr; 39(4):1640-1648. PubMed ID: 29393483
[TBL] [Abstract][Full Text] [Related]
52. Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine.
Derakhshani A; Hashemzadeh S; Asadzadeh Z; Shadbad MA; Rasibonab F; Safarpour H; Jafarlou V; Solimando AG; Racanelli V; Singh PK; Najafi S; Javadrashid D; Brunetti O; Silvestris N; Baradaran B
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067631
[TBL] [Abstract][Full Text] [Related]
53. TGF-β1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells.
Singh R; Shankar BS; Sainis KB
Cell Signal; 2014 Jul; 26(7):1604-15. PubMed ID: 24705025
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
[TBL] [Abstract][Full Text] [Related]
55. The expression and immunoregulation of immune checkpoint molecule VISTA in autoimmune diseases and cancers.
Wang G; Tai R; Wu Y; Yang S; Wang J; Yu X; Lei L; Shan Z; Li N
Cytokine Growth Factor Rev; 2020 Apr; 52():1-14. PubMed ID: 32057701
[TBL] [Abstract][Full Text] [Related]
56. VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.
Huang X; Zhang X; Li E; Zhang G; Wang X; Tang T; Bai X; Liang T
J Hematol Oncol; 2020 Jun; 13(1):83. PubMed ID: 32600443
[TBL] [Abstract][Full Text] [Related]
57. CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes.
Shi L; Meng T; Zhao Z; Han J; Zhang W; Gao F; Cai J
Gene; 2017 Dec; 636():36-41. PubMed ID: 28888577
[TBL] [Abstract][Full Text] [Related]
58. Role of LAP
Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
[TBL] [Abstract][Full Text] [Related]
59. Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Noelle RJ; Lines JL; Lewis LD; Martell RE; Guillaudeux T; Lee SW; Mahoney KM; Vesely MD; Boyd-Kirkup J; Nambiar DK; Scott AM
Front Oncol; 2023; 13():1225081. PubMed ID: 37795437
[TBL] [Abstract][Full Text] [Related]
60. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
El Din GS; Youness RA; Assal RA; Gad MZ
Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
